Objectives. Trans-diagnostic approaches suggest that key cognitive and behavioural processes maintain symptoms across a wide range of mental health disorders. Fatigue is a common clinical feature of attention deficit hyperactivity disorder (ADHD) in adulthood; however, empirical data supporting its prevalence are lacking. This study aimed to collate outcomes from outpatient services to (1) investigate the prevalence of fatigue in adults with ADHD, (2) examine symptoms of ADHD in adults with chronic fatigue syndrome (CFS), and (3) consider secondary clinical characteristics common to both disorder groups.
Practitioner points
Fatigue is a common clinical feature of attention deficit hyperactivity disorder (ADHD) in adulthood. Evidence-based interventions for chronic fatigue syndrome could be adapted to address fatigue in ADHD in adults.
hyperactive/impulsive subtype may be particularly at risk of fatigue as they grow older. Saez-Francas et al. (2012) found that CFS patients with comorbid ADHD had earlier fatigue onset, more severe anxiety, and depression and were at higher risk of suicide than those without ADHD comorbidity. Rates of suicide are also higher in CFS than in the general population (Roberts, Wessely, Chalder, Chang, & Hotopf, 2016) . In the light of this, further research is required to better understand the trans-diagnostic processes that underlie this high-risk subgroup of patients.
Trans-diagnostic approaches propose that fundamental cognitive (e.g., attention, memory, reasoning, thoughts) and behavioural (e.g., experiential avoidance) processes underlie a wide range of mental health disorders (Harvey, Watkins, Mansell, & Shafran, 2004; Hayes, Wilson, Gifford, Follette, & Strosahl, 1996) . Viewing different disorders through a shared trans-diagnostic lens highlights common processes that maintain symptoms across disorder groups. The Research Domain Criteria (RDoC) project highlights that dysfunctions in certain behavioural functions and neural circuits (e.g., working memory, emotion regulation) are common across many disorder groups listed in the DSM or the International Classification of Diseases and Related Health Problems. RDoC advocate for an empirically validated, dimensional approach to disorder classification (Cuthbert & Insel, 2013) . Adopting a trans-diagnostic approach is one way of understanding psychiatric comorbidity, facilitating transference of knowledge between new and established disorders and advancing developments in trans-diagnostic treatments (Mansell, Harvey, & Shafran, 2008) .
Developing trans-diagnostic treatments not only facilitates the generalization of treatment benefits across disorder groups in a more cost-effective manner, but also aids the development of more flexible treatment protocols for research purposes (McEvoy, Nathan, & Norton, 2009 ). Hence, evidence-based cognitive behavioural therapy (CBT) interventions proven to be effective in reducing fatigue and psychological distress in CFS (Deale, Chalder, Marks, & Wessely, 1997; Prins et al., 2001; Quarmby, Rimes, Deale, Wessely, & Chalder, 2007; Sharpe et al., 1996; White et al., 2011) could be adapted to target fatigue in adults with ADHD. Whilst consideration of all of the trans-diagnostic processes underlying CFS and ADHD is beyond the scope of this study, a proportion of their shared clinical characteristics will be considered.
Many adults with ADHD present with significant cognitive difficulties, particularly in areas of complex attention, executive functioning, processing speed and memory (Hervey, Epstein, & Curry, 2004; Woods, Lovejoy, & Ball, 2002) . Many adults with CFS also present with impairments in these areas (Cockshell & Mathias, 2013; DeLuca, Johnson, Beldowicz, & Natelson, 1995; DeLuca, Johnson, Ellis, & Natelson, 1997; Tiersky, Johnson, Lange, Natelson, & DeLuca, 1997) . Attentional processes, such as hypervigilance and attentional avoidance, have been hypothesized to play an active causal role in the maintenance of a variety of psychological disorders (Mansell et al., 2008) . Individuals with a particular disorder may selectively overattend (hypervigilance) or ignore (avoid) stimuli that relate to their primary concerns. In terms of hypervigilance, studies have shown that adults with CFS perceive exertion at lower heart rates than matched controls during exercise tasks (Gibson, Carroll, Clague, & Edwards, 1993) and respond more quickly to health threat-related words, such as 'collapse' and 'hospitalization' on the Visual Probe Task (Hou et al., 2014) . Clinical reports of hyperfocus on very stimulating or rewarding tasks are also common amongst adults with ADHD. Clinical reports of 'boom and bust' behavioural patterns are also frequent in both groups, characterized by overexertion and excessive rest in adults with CFS and extremes of behavioural impulsivity and task avoidance in adults with ADHD.
Sleep-related difficulties have also been identified as a trans-diagnostic process common to many psychiatric disorders, contributing not only to symptom onset, but also relapse and symptom maintenance (Harvey, 2008) . Sleep disorders take many forms including insomnia, hypersomnia, delayed sleep phase, and nocturnal panic attacks (Harvey, 2008; Harvey, Murray, Chandler, & Soehner, 2011) . Once considered an epiphenomenon, insomnia is now regarded as a fundamental factor in the aetiology and maintenance of many psychiatric disorders (Harvey, 2008) . Sleep problems have long been associated with ADHD, such that disrupted sleep was previously a diagnostic criterion until its removal from the DSM-III (DSM-III; American Psychiatric Association, 1987) . Studies have shown significantly higher prevalence rates of delayed sleep phase syndrome and sleep-onset insomnia in adults with ADHD (Bijlenga et al., 2013; Fisher et al., 2014; Van Veen, Kooij, Boonstra, Gordijn, & Van Someren, 2010) . Subjective and objective sleep disorders are also common in CFS (Buchwald, Pascualy, Bombardier, & Kith, 1994; Krupp, Jandorf, Coyle, & Mendelson, 1993; Morriss et al., 1993) . Hence, poor sleep may exacerbate core symptoms and associated difficulties of ADHD and CFS. Further consideration of their trans-diagnostic processes may illuminate the nature of fatigue in adult ADHD.
Whilst each disorder represents a heterogeneous group, a number of shared transdiagnostic processes are evident in terms of fatigue, mood, cognitive, and sleep-related difficulties (see Figure 1 ). To the authors' knowledge, trans-diagnostic processes in adult ADHD and CFS have not yet been investigated in a UK outpatient setting. Primarily, this study aimed to investigate the prevalence of fatigue in an adult ADHD population and the prevalence of ADHD symptoms (i.e., inattention, hyperactivity, and impulsivity) in an adult CFS population. Trans-diagnostic processes underlying both clinical groups will also be investigated using self-report measures of mood, anxiety, functional impairment, sleep, self-efficacy, and participants' beliefs about the acceptability of expressing emotions. It is hypothesized that ADHD participants will report significantly higher levels of selfreported fatigue and CFS participants will report significantly greater ADHD symptoms than healthy controls (HC). ADHD and CFS groups will not differ significantly on secondary trans-diagnostic measures. students from a local university were also recruited to form a healthy control comparison group (N = 243). Participants were excluded using the following criteria: verbal IQ < 80, non-fluent in English, presence of a primary mood, psychosis, personality or pervasive developmental disorder, current risk to self or others, active substance misuse/dependence within the last 3 months, or history of an acquired brain injury. Attention deficit hyperactivity disorder participants were assessed by a consultant psychiatrist experienced in diagnosing ADHD in adulthood. DSM-IV criteria were established using a structured diagnostic interview, as these were the most up-to-date DSM criteria available at the time of the study. Collateral information was obtained from an informant to confirm childhood onset of symptoms as suggested in diagnostic guidelines (National Collaborating Centre for Mental Health, 2008) . A psychiatric assessment was also made to exclude any other organic or psychiatric causes of ADHD symptoms. CFS participants were assessed by a physician or CBT therapist experienced in diagnosing CFS. CFS participants met Centers for Disease Control and Prevention or Oxford criteria for CFS, established using a semistructured diagnostic interview and a medical screening examination to exclude any other organic or psychiatric causes of fatigue as outlined in diagnostic guidelines (Sharpe, Chalder, Palmer, & Wessely, 1997; Sharpe et al., 1991) .
Methods

Participants
Procedure
Questionnaires and instructions for completion were posted to participants alongside additional pre-therapy outcome measures routinely obtained prior to client's engagement with CBT. Completion of measures listed in this study is estimated to have taken participants between 20 and 30 min. Data were included where participants provided written consent allowing their measures to be included in future audits and research projects within each service. Participants returned questionnaires to clinicians during therapy sessions. Reminders were provided by clinicians as necessary to support data collection. Information regarding the return rate is unfortunately unavailable; however, it is estimated that most participants attending CBT completed their measures as this is part of pre-therapy standard clinical procedures.
Measures
Demographic and clinical characteristics
Information regarding the participants' demographic characteristics (age, gender, ethnicity, relationship status, education level) was obtained using a self-report measure. Participants were also asked to declare any previous episodes of fatigue, which warranted General Practitioner (GP) attention as well as the presence of any current physical or mental health concerns.
Chalder Fatigue Scale (Cella & Chalder, 2010; Chalder et al., 1993) This is an 11-item self-report measure of physical and mental fatigue. Participants rate fatigue experienced over the past month compared with their usual energy levels using a 4-point Likert scale, where 0 = 'less than usual' and 3 = 'much more than usual'. Scores range from 0 to 33. A bimodal version can also be calculated, where scores range from 0 to 11, with a cut-off score of 4 or more indicating fatigue caseness. This scale has excellent consistency with a Cronbach's alpha of .95 in the current sample.
Barkley's Current Symptom Scale (Barkley & Murphy, 2006) This is an 18-item self-report measure denoting ADHD diagnostic criteria as outlined in the DSM-IV (American Psychiatric Association, 2000). Items assess the frequency of nine inattentive symptoms and nine hyperactive and impulsive symptoms. Participants rate the frequency of each symptom on a 4-point Likert scale, where 0 = never and 3 = often. Scores range from 0 to 54. A score of 2 or more on each item is indicative of symptom presence. A cut-off point of six or more items in each domain is suggestive of clinically significant inattention or hyperactivity and impulsivity. This measure has strong reliability and validity, and it has been widely used in ADHD research. In the current study, internal consistency for each subscale was excellent (inattention = .97, hyperactivity and impulsivity = .95).
Work and Social Adjustment Scale (Mundt, Marks, Shear, & Greist, 2002) This is a 5-item self-report measure of functional impairment in occupational and social settings. Participants rate each item on a 9-point Likert scale, where 0 = not impaired at all and 8 = very severely impaired. Scores range from 0 to 40. A reduction of eight points or more is suggestive of a clinically significant improvement (Zahra et al., 2014) . The Work and Social Adjustment Scale is a reliable and valid measure that has been widely used to assess functionality in relation to a number of different disorders (Cella, Sharpe, & Chalder, 2011; Mataix-Colsa et al., 2005) . This scale has excellent internal consistency in the current sample with a reported Cronbach's alpha of .94.
Hospital Anxiety and Depression Scale (Zigmond & Snaith, 1983) This measure comprises 14 items, where seven items measure symptoms of anxiety and seven items measure symptoms of depression. Scores ranging from 0 to 7 fall within the 'normal' range, 8-10 'mild' range, 11-14 'moderate' range, and 15-21 'severe' range. A mean Cronbach's alpha coefficient of .83 has been reported for the anxiety subscale and .82 for the depression subscale. The Hospital Anxiety and Depression Scale (HADS) is an effective tool for assessing symptom severity in anxiety and somatic disorders in psychiatric and primary care settings as well as in the general population (Bjellanda, Dahlb, Haugc, & Neckelmannd, 2002) . Internal consistency for both subscales was good in the current population (anxiety = .89 and depression = .83).
Jenkins Sleep Evaluation Questionnaire (Jenkins, Stanton, Niemcryk, & Rose, 1988) This measure comprises four items rated on a 6-point scale. Items ask how frequently during the previous 4 weeks the respondent has experienced (1) difficulty falling asleep, (2) difficulty staying asleep, (3) waking up several times per night, and (4) waking up feeling tired and worn out after the usual amount of sleep. Response options include 0 = not at all; 1 = 1-3 days; 2 = 4-7 days; 3 = 8-14 days; 4 = 15-21 days; and 5 = 22-28 days. Scores range from 0 to 20, where higher scores are suggestive of a greater number of sleep problems. This scale also has acceptable internal consistency with Cronbach's alphas ranging from .63 to .79 in cardiac and fibromyalgia patients (Crawford, Piault, Lai, & Sarzi-Puttini, 2010) and .78 in the current sample.
Generalized Self-Efficacy Scale (Schwarzer & Jerusalem, 1995) This measure is a 10-item scale measuring the respondent's capability to handle new and difficult tasks in a variety of different domains. Responses are rated on a 4-point scale, where 1 = not at all true, 2 = hardly true, 3 = moderately true, and 4 = exactly true. Scores range from 10 to 40 with higher scores indicating greater self-efficacy. This measure has been validated cross-nationally, with Cronbach's alphas range from .86 to .94 in patients with cardiovascular disease, cancer, gastrointestinal disease, and HC (Luszczynska, Scholz, & Schwarzer, 2005 ). Cronbach's alpha in the current sample was .92.
Beliefs about emotions (Rimes & Chalder, 2010) This is a 12-item self-report scale measuring beliefs about the unacceptability of experiencing and expressing emotion. Items are rated on a 7-point Likert scale, where 0 = totally agree and 6 = totally disagree. Higher scores represent more maladaptive beliefs. The Beliefs about emotions (BAE) has good internal consistency with Cronbach's alphas of .91 in individuals with CFS and .90 in the current sample.
Statistical analysis
Statistical analysis was performed using the IBM Statistical Package for the Social Sciences, version 22.0 (IBM Corp, Armonk, NY, USA). As assumptions of normality were violated, nonparametric analyses were used. Missing items were replaced with mean scores, and where more than 25% of items were missing, data were excluded. However, it is noteworthy that >98% of the overall sample completed over 75% of items on each measure. All significance test results are quoted as two-tailed and significance levels of .05 are reported for all tests, unless otherwise specified.
Chi-square analyses were performed to investigate differences between CFS, ADHD, and HC groups on demographic and clinical characteristics, with the exception of age that was investigated using a Kruskal-Wallis test.
Between-groups differences on measures of fatigue, ADHD symptoms, mood, anxiety, functional impairment, sleep, self-efficacy, and BAE were investigated using multiple Kruskal-Wallis tests. A further Kruskal-Wallis test was performed on the HADS anxiety subscale with items A1, A4, and A6 removed to control for physical restlessness as a possible confounding variable with ADHD symptoms.
Adjusted significance values were interpreted to account for multiple comparisons across the three participant groups. The percentage of participants in each group meeting criteria for caseness in fatigue, depression, anxiety, inattention, and hyperactivity or impulsivity were compared using chi-square analyses.
Ethical approval
Ethical approval was received from the relevant local committee. The nature and purpose of the study was fully explained to participants prior to obtaining informed consent.
Results
Demographic characteristics
Results illustrate that CFS (N = 86), ADHD (N = 204), and HC (N = 243) groups differed significantly across demographic and clinical characteristics. Medians (Mdn), interquartile ranges (IQR), and test statistics for Kruskal-Wallis and chi-square analyses are reported in Table 1 . Adjusted significance values are reported for Kruskal-Wallis post-hoc analyses to account for multiple comparisons.
A significant difference in age was found across CFS, ADHD, and HC groups; however, post-hoc analyses failed to detect any significant pairwise comparisons. Significant gender differences were also observed across participant groups, with 70% of the ADHD group comprising males compared with only 27% of CFS and HC groups, respectively. The ADHD group were more ethnically diverse, with 23% identifying as other than white British, compared with 19% of CFS and 8% of HC groups. ADHD and CFS groups were similar in terms of education and relationship status, with approximately half of each group educated to university level and a third identifying as married or living together. This contrasted with the HC group, of whom a greater proportion was educated to university level (88%) and married or living together (52%).
Clinical characteristics
Forty-five percentage of ADHD participants declared that they had previously experienced an episode of fatigue that warranted GP attention, compared with only 17% of HC participants. Recent reports of physical and mental health concerns were more common in patient groups than in HC. CFS participants (34%) were more likely to present with a current physical health concern than ADHD participants (23%). Approximately half of both patient groups reported current mental health problems.
Between-groups comparisons for fatigue A significant range of fatigue scores were observed within and across participant groups (see Figure 2) . Kruskal-Wallis tests demonstrated a significant between-groups difference for fatigue. Post-hoc comparisons revealed that the ADHD group reported significantly lower levels of fatigue than the CFS group. However, the ADHD group did report significantly higher levels of fatigue than controls. This pattern was also observed for both the physical and mental fatigue subscales (see Table 2 ). Results of a chi-square analysis detected a significant difference between participant groups regarding the percentage of participants meeting the Chalder et al.'s (1993) criteria for fatigue caseness. The ADHD group (62%) had fewer participants meeting caseness for fatigue than the CFS group (86%); however, the ADHD group had considerably more participants meeting criteria than the HC group (26%).
Between-groups comparisons for ADHD symptoms
Kruskal-Wallis tests demonstrated a significant between-groups difference for ADHD symptoms (see Table 3 ). Perhaps unsurprisingly, post-hoc analyses revealed significantly higher Barkley scores in the ADHD group than in either comparison group. However, interestingly, the CFS group also obtained significantly higher ADHD scores than controls.
A chi-square test revealed a significant difference between ADHD, CFS, and HC groups in terms of the percentage participants in each group meeting criteria for symptom presence (i.e., positive responses to six of nine criteria in each domain). Seventy-three Note. HC = healthy controls; CFS = chronic fatigue syndrome; ADHD = attention deficit hyperactivity disorder; N = number; df = degrees of freedom; p = probability value; Mdn = median; IQR = interquartile range. (3) 25 (13) 16.25 (9) 131.42 (2, 385)
.0001
17 (8) 9 (5) 120.6 (2, 385)
.0001 .0001
CFS
Note. HC = healthy controls; CFS = chronic fatigue syndrome; ADHD = attention deficit hyperactivity disorder; N = number; df = degrees of freedom; p = probability value; Mdn = median; IQR = interquartile range. .0001
Note. HC = healthy controls; CFS = chronic fatigue syndrome; ADHD = attention deficit hyperactivity disorder; N = number; df = degrees of freedom; p = probability value; Mdn = median; IQR = interquartile range.
percentage of ADHD participants met criteria for inattention symptom presence, compared with 12% of CFS and 0% of controls. A lesser proportion of ADHD participants met criteria for hyperactivity and impulsivity symptom presence (44%) compared with only 6% of CFS and 0% of controls.
Between-groups comparisons for trans-diagnostic measures A further series of Kruskal-Wallis tests detected significant between-groups differences across all secondary clinical measures (Table 4) . There were no significant post-hoc differences between the ADHD and CFS groups on the HADS depression subscale; however, both patient groups reported significantly higher levels of depression than controls. A similar proportion of patients in the ADHD and CFS groups reported mild symptoms of depression or higher (46% and 48%, respectively). These rates were considerably higher than those observed in the control group (8.5%).
Post-hoc analyses revealed significantly higher HADS anxiety scores in the ADHD group than in the CFS group, with both patient groups reporting significantly higher anxiety than the HC group. Seventy-nine percentage of ADHD participants reported mild symptoms of anxiety or higher, compared with 56% and 29% of CFS and controls.
Group HADS anxiety scores were again compared with confounding items relating to physical restlessness as a confounding ADHD symptoms variable (e.g., item A1 'I feel tense of "wound up"') omitted. Post-hoc analyses failed to detect a significant difference between ADHD and CFS groups; however, both clinical groups continued to report significantly higher scores than controls.
There were no significant post-hoc differences between the ADHD and CFS groups on measures of functional impairment and self-efficacy, with both patient groups significantly more impaired than controls.
Post-hoc analyses revealed a significantly higher number of sleep-related difficulties in the CFS group than in the ADHD group, with both patient groups reporting significantly more sleep-related difficulties than controls.
The ADHD group reported significantly higher scores than CFS group on the BAE measure; however, no significant differences were detected between the CFS group and controls.
Discussion
This study primarily aimed to investigate the prevalence of fatigue in an adult ADHD outpatient population. Whilst many studies have focused on sleep-related difficulties in adult ADHD (Bijlenga et al., 2013; Fisher et al., 2014; Philipsen, Hornyak, & Riemann, 2006; Van Veen et al., 2010) , there has been a dearth of research investigating fatigue. Results suggest that fatigue is significantly greater in adults with ADHD than in HC. This trend was observed for both physical and mental fatigue, with 63% of ADHD participants meeting the Chalder et al.'s (1993) criteria for fatigue caseness. Whilst the chronicity of fatigue was not formally assessed in this study, 45% of participants in the ADHD group reported having previously experienced an episode of fatigue that warranted GP attention. Fatigue prevalence rates reported here are comparable with those from a brief survey carried out with adults with ADHD (Young & Saal, 2012) and vastly exceed those of fatigue reported in primary care settings (Pawlikowska et al., 1994; Wessely et al., 1997) . 28 (18) 22 (18) 318. 43 (2, 514) .0001
7 (7) 7 (7) 160.47 (2, 505)
8.5 (7) 12 (6) 120 . (7) 29 (4) 28 (10) 79.39 (2, 367)
Beliefs about emotions 34 (19) 38 (25) 40 (19) 31.68 (2, 475) .0001 Hence, initial results suggest that fatigue is a common yet underrecognized clinical feature of ADHD in adulthood.
In comparison with the CFS group, the ADHD group were significantly less fatigued. Although fatigue is the primary concern of those with CFS and regarded as an epiphenomenon in ADHD, sleep problems were significantly higher in the CFS group, and as such, this finding may have been a confounding variable as links between sleeprelated difficulties and daytime fatigue are well recognized in this group (Buchwald et al., 1994; Krupp et al., 1993; Morriss et al., 1993) . Hence, discrepancies noted between CFS and ADHD groups in this study cannot be assumed to reflect differences in fatigue alone.
The secondary aim of this study was to investigate the prevalence of ADHD symptoms (i.e., inattention, hyperactivity and impulsivity) in adults with CFS. Almost 12% of the CFS group reported symptoms of inattention reaching clinical significance and 6% reported symptoms of hyperactivity and impulsivity reaching clinical significance. These scores are considerably lower than those detected in the ADHD group (73% and 44%, respectively); however, they vastly exceed those found in the control group (<1%). Although other studies have observed prevalence rates of up to 21% in the CFS population (de Graaf et al., 2008; Saez-Francas et al., 2012) , self-report measures of ADHD symptoms cannot be assumed diagnostic when considered in isolation. Self-report measures form only one part of a comprehensive adult ADHD assessment according to diagnostic guidelines. Nonetheless, self-report scores reported here suggest that attentional difficulties are more prevalent in the CFS group than in the control group. These results are in keeping with reports of attention and information processing speed difficulties noted in the wider CFS literature (Cockshell & Mathias, 2013; DeLuca et al., 1995 DeLuca et al., , 1997 Tiersky et al., 1997) .
Lastly, this study aimed to investigate trans-diagnostic processes underlying ADHD and CFS. Results suggest that both clinical groups performed homogenously across a range of secondary clinical measures, including mood, functional impairment, and self-efficacy. Approximately half of both clinical groups met caseness for mild depression. Initial results suggest that ADHD participants were considerably more anxious than CFS participants; however, when items relating to physical restlessness (e.g., 'I feel tense or "wound up"') were removed due to their confounding relationship with ADHD symptoms, no significant differences were found between the two groups. These results are consistent with rates of psychiatric comorbidity found in both groups (Afari & Buchwald, 2003; Kessler et al., 2006; Wessely et al., 1997) and support the hypothesis that there are shared trans-diagnostic processes common across disorder groups (Mansell et al., 2008) , shedding further light on why almost half of all psychological disorders are found to be comorbid (Cuthbert & Insel, 2013; Kessler, Chiu, Demler, & Walters, 2005) .
Benefits of adopting a trans-diagnostic approach to mental health difficulties have been well documented, not least those relating to the generalization of knowledge from established models to new psychological phenomena (Harvey et al., 2004; Mansell et al., 2008) . Results from this study suggest that screening for fatigue in adult ADHD services would be beneficial, such that fatigue management information already available for other conditions (e.g., chronic fatigue) could be provided to clients at an early stage before symptoms become functionally impairing. Furthermore, where fatigue is deemed to be more severe, established CBT treatment manuals for fatigue (Burgess & Chalder, 2005; Deale et al., 1997; Quarmby et al., 2007) could be adapted for use with adults with ADHD. These could help address such maintaining factors as 'boom and bust' behaviours in everyday tasks, negative self-beliefs, and unhelpful emotional regulation strategies, such as experiential avoidance. An individualized, formulation-based CBT approach to treating associated difficulties of ADHD in adulthood (Dittner, Rimes, Russell, & Chalder, 2014) would make it possible to target such maintaining difficulties directly.
Likewise, patients with CFS would benefit from psychoeducation regarding the nature of cognition and factors that affect memory, attention, and concentration, in addition to specific skills training to improve inattention, hyperactivity, and impulsivity (e.g., help with planning and organization). Patients with CFS may also benefit from therapeutic interventions which target negative self-beliefs that arise from difficulties with attention and concentration, as these beliefs may impact upon mood, self-efficacy, and functional capabilities.
A number of limitations must also be noted with regard to the findings of this study. In terms of the sample recruited, ADHD and CFS participants were attending national specialist services and therefore results may not be representative of local services. Equally, groups were not matched on socio-demographic variables (e.g., gender, age, and ethnicity). However, clinical groups did not differ significantly in terms of age, educational background, and relationship status. Indeed, 88% of HC were university educated, and hence, their results may not reflect the distribution of cognitive and mood-related difficulties found in the general population. As questionnaires were completed by participants independently, it is possible that questionnaires were susceptible to fatigue effects and counterbalancing was not implemented. It is also possible that less impaired participants were more likely to complete and return questionnaires, and hence, results presented in this study may not be completely representative. However, it is noteworthy that 86% of CFS participants in this study met the Chalder et al.'s (1993) criteria for fatigue and 100% reported fatigue as a significant problem at the time of assessment. Hence, CFS participants were assumed to suffer from significant and debilitating fatigue.
In conclusion, there appear to be a number of trans-diagnostic processes common to both ADHD and CFS, as indicated by the results of this study. Clinical features of fatigue in addition to attentional, sleep, and mood-related difficulties appear to be present to varying degrees in both clinical populations. Research suggests that patients meeting criteria for both disorders are at high risk of suicidality and mortality (Roberts et al., 2016; SaezFrancas et al., 2012) ; hence, further evaluation into fatigue in adult ADHD is required to meet the needs of this complex client group. Developments towards trans-diagnostic treatments also pose exponential benefits to public health and clinical service providers, in terms of providing cost-efficient interventions to meet the needs of a range of service users across mental health services, whilst reducing training requirements and treatment waiting times (McEvoy et al., 2009) .
